Retrospective assessment of transcription-mediated amplification-based screening for Trichomonas vaginalis in male sexually transmitted infection clinic patients

Journal of Clinical Microbiology

Volumn 51, Issue 6, 2013, Pages 1855-1860

  Munson, Erik ^a,b   Wenten, David ^c   Phipps, Paula ^c   Gremminger, Roger ^c   Schuknecht, Mary Kay ^c   Napierala, Maureen ^a   Hamer, Deb ^a,c   Olson, Robin ^a   Schell, Ronald F ^d,e   Hryciuk, Jeanne E ^a  

^a Wheaton Franciscan Laboratory   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c STD Specialties Clinic   (United States)

^d WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASYMPTOMATIC INFECTION; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; HETEROSEXUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL; RECTUM; RETROSPECTIVE STUDY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; SYMPTOMATOLOGY; THROAT CULTURE; TRANSCRIPTION MEDIATED AMPLIFICATION; TRICHOMONAS VAGINALIS; URINALYSIS;

ADULT; AMBULATORY CARE FACILITIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PARASITOLOGY; PHARYNX; PREVALENCE; SEXUALLY TRANSMITTED DISEASES; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS; YOUNG ADULT;

CHLAMYDIA TRACHOMATIS; NEISSERIA GONORRHOEAE; TRICHOMONAS VAGINALIS;

EID: 84878480360     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00455-13     Document Type: Article

References (34)

1. Weinstock H, Berman S, Cates W, Jr. 2004. Sexually transmitted diseases among American youth: incidence and prevalence estimates. Perspect. Sex. Reprod. Health 36:6-10. (Pubitemid 38258322)
2. Andrea SB, Chapin KC. 2011. Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD Affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications. J. Clin. Microbiol. 49:866-869.
3. Huppert JS, Hesse E, Kim G, Kim M, Agreda P, Quinn N, Gaydos C. 2010. Adolescent women can perform a point-of-care test for trichomoniasis as accurately as clinicians. Sex. Transm. Infect. 86:514-519.
4. Munson E, Napierala M, Olson R, Endes T, Block T, Hryciuk JE, Schell RF. 2008. Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence. J. Clin. Microbiol. 46:3368-3374.
5. Nye MB, Schwebke JR, Body BA. 2009. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am. J. Obstet. Gynecol. 200:188.e1-188.e7.
6. Schwebke JR, Lawing LF. 2002. Improved detection by DNA amplification of Trichomonas vaginalis in males. J. Clin. Microbiol. 40:3681-3683.
7. Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. 2003. Use of urine polymerase chain reaction to define the prevalence and clinical presentation of Trichomonas vaginalis in men attending an STD clinic. Sex. Transm. Infect. 79:151-153. (Pubitemid 36469623)
8. Guatelli JC, Whitfield KM, Kwoh DY, Barringer KJ, Richman DD, Gingeras TR. 1990. Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication. Proc. Natl. Acad. Sci. U. S. A. 87:1874-1878.
9. Hardick A, Hardick J, Wood BJ, Gaydos C. 2006. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples. J. Clin. Microbiol. 44:4197-4199. (Pubitemid 44737270)
10. Napierala M, Munson E, Munson KL, Kramme T, Miller C, Burtch J, Olson R, Hryciuk JE. 2011. Three-year history of transcription-mediated amplification-based Trichomonas vaginalis analyte-specific reagent testing in a subacute care patient population. J. Clin. Microbiol. 49:4190-4194.
11. Munson KL, Napierala M, Munson E, Schell RF, Kramme T, Miller C, Hryciuk JE. 2013. Screening of male patients for Trichomonas vaginalis with transcription-mediated amplification in a community with a high prevalence of sexually-transmitted infection. J. Clin. Microbiol. 51 : 101-104.
12. Bachmann LH, Johnson RE, Cheng H, Markowitz L, Papp JR, Palella FJ, Jr, Hook EW, III. 2010. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections. J. Clin. Microbiol. 48:1827-1832.
13. Whiley DM, Buda PP, Freeman K, Pattle NI, Bates J, Sloots TP. 2005. A real-time PCR assay for the detection of Neisseria gonorrhoeae in genital and extragenital specimens. Diagn. Microbiol. Infect. Dis. 52:1-5. (Pubitemid 40692733)
14. Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. 2008. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex. Transm. Dis. 35:637-642.
15. Ota KV, Tamari IE, Smieja M, Jamieson F, Jones KE, Towns L, Juzkiw J, Richardson SE. 2009. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD Probetec ET system, the Gen-Probe Aptima Combo 2 assay and culture. Sex. Transm. Infect. 85:182-186.
16. Moncada J, Donegan E, Schachter J. 2008. Evaluation of CDC-recommended approaches for confirmatory testing of positive Neisseria gonorrhoeae nucleic acid amplification test results. J. Clin. Microbiol. 46:1614-1619. (Pubitemid 351657203)
17. Page-Shafer K, Graves A, Kent C, Balls JE, Zapitz VM, Klausner JD. 2002. Increased sensitivity of DNA amplification testing for detection of pharyngeal gonorrhea in men who have sex with men. Clin. Infect. Dis. 34:173-176. (Pubitemid 34028348)
18. Bachmann LH, Johnson RE, Cheng H, Markowitz LE, Papp JR, Hook EW, III. 2009. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections. J. Clin. Microbiol. 47:902-907.
19. Rosenstraus M, Wang Z, Chang S-Y, DeBonville D, Spadoro JP. 1998. An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance. J. Clin. Microbiol. 36:191-197. (Pubitemid 28047457)
20. Monteiro L, Bonnemaison D, Vekris A, Petry KG, Bonnet J, Vidal R, Cabrita J, Mégraud F. 1997. Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J. Clin. Microbiol. 35:995-998. (Pubitemid 27146555)
21. Centers for Disease Control and Prevention. 2012. Sexually transmitted disease surveillance, 2011. U.S. Department of Health and Human Services, Atlanta, GA.
22. Gaydos CA, Quinn TC, Willis D, Weissfeld A, Hook EW, Martin DH, Ferrero DV, Schachter J. 2003. Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J. Clin. Microbiol. 41:304-309. (Pubitemid 36098592)
23. Munson E, Napierala M, Basile J, Miller C, Burtch J, Hryciuk JE, Schell RF. 2010. Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent and alternative target testing of primary clinical vaginal saline suspensions. Diagn. Microbiol. Infect. Dis. 68 : 66-72.
24. Munson E, Kramme T, Napierala M, Munson KL, Miller C, Hryciuk JE. 2012. Female epidemiology of transcription-mediated amplification-based Trichomonas vaginalis detection in a metropolitan setting with a high prevalence of sexually-transmitted infection. J. Clin. Microbiol. 50:3927-3931.
25. Mahony J, Chong S, Jang D, Luinstra K, Faught M, Dalby D, Sellors J, Chernesky M. 1998. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J. Clin. Microbiol. 36:3122-3126. (Pubitemid 28476150)
26. Chernesky M, Jang D, Luinstra K, Chong S, Smieja M, Cai W, Hayhoe B, Portillo E, MacRitchie C, Main C, Ewert R. 2006. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay. J. Clin. Microbiol. 44:400-405.
27. Ikeda-Dantsuji Y, Konomi I, Nagayama A. 2005. In vitro assessment of the APTIMA Combo 2 assay for the detection of Chlamydia trachomatis using highly purified elementary bodies. J. Med. Microbiol. 54:357-360. (Pubitemid 40489541)
28. Krashin JW, Koumans EH, Bradshaw-Sydnor AC, Braxton JR, Evan Secor W, Sawyer MK, Markowitz LE. 2010. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Sex. Transm. Dis. 37:440-444.
29. Hersh SM. 1985. Pulmonary trichomoniasis and Trichomonas tenax. J. Med. Microbiol. 20:1-10. (Pubitemid 15042283)
30. Kucknoor AS, Mundodi V, Alderete JF. 2009. Genetic identity and differential gene expression between Trichomonas vaginalis and Trichomonas tenax. BMC Microbiol. 9:58. doi:10.1186/1471-2180-9-58.
31. Gen-Probe. 2011. APTIMA Trichomonas vaginalis assay package insert. Gen-Probe, Incorporated, San Diego, CA. http://gen-probe.com/pdfs/pi/502246-EN- RevB.pdf.
32. Crucitti T, Jespers V, Mulenga C, Khondowe S, Vandepitte J, Buvé A. 2010. Trichomonas vaginalis is highly prevalent in adolescent girls, pregnant women, and commercial sex workers in Ndola, Zambia. Sex. Transm. Dis. 37:223-227.
33. Press N, Chavez VM, Ticona E, Calderon M, Apolinario IS, Culotta A, Arevalo J, Gilman RH; the Working Group on AIDS in Peru. 2001. Screening for sexually transmitted diseases in human immunodeficiency virus-positive patients in Peru reveals an absence of Chlamydia trachomatis and identifies Trichomonas vaginalis in pharyngeal specimens. Clin. Infect. Dis. 32:808-814. (Pubitemid 32221941)
34. Cosentino LA, Campbell T, Jett A, Macio I, Zamborsky T, Cranston RD, Hillier SL. 2012. Use of nucleic acid amplification testing for diagnosis of anorectal sexually transmitted infections. J. Clin. Microbiol. 50:2005-2008.